Chemours (CC) Financials

$23.76 -4.19 (-14.98%)

Closing price 05/6/2026 03:59 PM Eastern

Extended Trading

$23.95 +0.20 (+0.83%)

As of 04:10 AM Eastern

Annual Income Statements for Chemours

This table shows Chemours' income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Period end date	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025
Net Income / (Loss) Attributable to Common Shareholders	-90	7.00	746	995	-52	219	608	578	-253	69	-386
Consolidated Net Income / (Loss)	-90	7.00	747	996	-52	219	608	578	-252	69	-386
Net Income / (Loss) Continuing Operations	-90	7.00	747	996	-52	219	608	578	-252	69	-386
Total Pre-Tax Income	-188	-11	912	1,155	-124	179	676	741	-318	106	-277
Total Operating Income	-132	-94	981	1,183	348	367	676	772	-245	319	-64
Total Gross Profit	955	1,103	1,745	1,971	1,063	1,067	1,381	1,616	1,302	1,142	902
Total Revenue	5,717	5,400	6,183	6,638	5,526	4,969	6,345	6,831	6,078	5,782	5,808
Operating Revenue	5,717	5,400	6,183	6,638	5,526	4,969	6,345	6,831	6,078	5,782	5,808
Total Cost of Revenue	4,762	4,297	4,438	4,667	4,463	3,902	4,964	5,215	4,776	4,640	4,906
Operating Cost of Revenue	4,762	4,297	4,438	4,667	4,463	3,902	4,964	5,215	4,776	4,640	4,906
Total Operating Expenses	1,087	1,197	764	788	715	700	705	844	1,547	823	966
Selling, General & Admin Expense	632	946	626	657	548	527	592	710	1,286	598	799
Research & Development Expense	97	81	81	82	80	93	107	118	108	109	108
Impairment Charge	358	-	-	-	-	-	-	0.00	0.00	56	0.00
Restructuring Charge	-	170	57	49	87	80	6.00	16	153	60	59
Total Other Income / (Expense), net	-56	83	-69	-28	-472	-188	0.00	-31	-73	-213	-213
Interest Expense	132	213	215	233	208	232	206	156	209	264	274
Interest & Investment Income	22	29	33	43	29	23	43	55	45	43	35
Other Income / (Expense), net	54	267	113	162	-293	21	163	70	91	8.00	26
Income Tax Expense	-98	-18	165	159	-72	-40	68	163	-66	37	109
Net Income / (Loss) Attributable to Noncontrolling Interest	0.00	0.00	1.00	1.00	-	-	0.00	0.00	1.00	0.00	0.00
Basic Earnings per Share	($0.50)	$0.04	$4.04	$5.62	($0.32)	$1.33	$3.69	$3.72	($1.70)	$0.46	($2.57)
Weighted Average Basic Shares Outstanding	180M	183.15M	184.84M	176.97M	164.01M	165.17M	160.02M	148.34M	148.80M	149.44M	150.09M
Diluted Earnings per Share	($0.50)	$0.04	$3.91	$5.45	($0.32)	$1.32	$3.60	$3.65	($1.70)	$0.46	($2.57)
Weighted Average Diluted Shares Outstanding	180M	183.15M	184.84M	176.97M	164.01M	165.17M	160.02M	148.34M	148.80M	149.44M	150.09M
Weighted Average Basic & Diluted Shares Outstanding	180M	183.15M	184.84M	176.97M	164.01M	165.17M	160.02M	148.34M	148.80M	149.44M	150.09M
Cash Dividends to Common per Share	$0.58	$0.12	$0.29	$0.67	$1.00	$1.00	$1.00	$1.00	$1.00	$1.00	$0.51

This table shows Chemours' income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025	Q4 2025
Period end date	6/30/2023	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024	3/31/2025	6/30/2025	9/30/2025	12/31/2025
Net Income / (Loss) Attributable to Common Shareholders	-376	12	-19	54	60	-32	-9.00	-4.00	-381	60	-61
Consolidated Net Income / (Loss)	-376	12	-18	54	60	-32	-9.00	-4.00	-380	60	-62
Net Income / (Loss) Continuing Operations	-376	12	-18	54	60	-32	-9.00	-4.00	-380	60	-62
Total Pre-Tax Income	-433	13	-71	70	69	-32	8.00	0.00	-261	51	-67
Total Operating Income	-396	-46	-5.00	115	125	19	70	53	-205	94	-6.00
Total Gross Profit	410	273	255	284	308	286	273	236	278	233	155
Total Revenue	1,643	1,487	1,412	1,362	1,554	1,508	1,393	1,368	1,615	1,495	1,330
Operating Revenue	1,643	1,487	1,412	1,362	1,554	1,508	1,393	1,368	1,615	1,495	1,330
Total Cost of Revenue	1,233	1,214	1,157	1,078	1,246	1,222	1,120	1,132	1,337	1,262	1,175
Operating Cost of Revenue	1,233	1,214	1,157	1,078	1,246	1,222	1,120	1,132	1,337	1,262	1,175
Total Operating Expenses	806	319	260	169	183	267	203	183	483	139	161
Selling, General & Admin Expense	779	165	222	137	154	137	169	123	437	109	130
Research & Development Expense	28	28	26	28	26	29	26	27	28	26	27
Restructuring Charge	-1.00	126	12	4.00	3.00	45	8.00	33	18	4.00	4.00
Total Other Income / (Expense), net	-37	59	-66	-45	-56	-51	-62	-53	-56	-43	-61
Interest Expense	48	56	63	63	66	68	67	66	67	68	73
Interest & Investment Income	13	13	7.00	13	11	11	8.00	8.00	9.00	9.00	9.00
Other Income / (Expense), net	-2.00	102	-10	5.00	-1.00	6.00	-3.00	5.00	2.00	16	3.00
Income Tax Expense	-57	1.00	-53	16	9.00	0.00	17	4.00	119	-9.00	-5.00
Basic Earnings per Share	($2.52)	$0.08	($0.13)	$0.36	$0.40	($0.22)	($0.06)	($0.03)	($2.54)	$0.40	($0.40)
Weighted Average Basic Shares Outstanding	148.08M	148.44M	148.80M	148.90M	149.27M	149.41M	149.44M	149.67M	149.70M	149.89M	150.09M
Diluted Earnings per Share	($2.52)	$0.08	($0.12)	$0.36	$0.39	($0.22)	($0.05)	($0.03)	($2.54)	$0.40	($0.40)
Weighted Average Diluted Shares Outstanding	148.08M	148.44M	148.80M	148.90M	149.27M	149.41M	149.44M	149.67M	149.70M	149.89M	150.09M
Weighted Average Basic & Diluted Shares Outstanding	148.08M	148.44M	148.80M	148.90M	149.27M	149.41M	149.44M	149.67M	149.70M	149.89M	150.09M

This table details how cash moves in and out of Chemours' business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Period end date	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025
Net Change in Cash & Equivalents	366	536	622	-340	-258	124	480	-215	503	-1,044	-68
Net Cash From Operating Activities	182	594	640	1,140	650	807	814	755	556	-633	264
Net Cash From Continuing Operating Activities	310	594	640	1,140	650	807	814	755	556	-633	264
Net Income / (Loss) Continuing Operations	-90	7.00	747	996	-52	219	608	578	-252	69	-386
Consolidated Net Income / (Loss)	-90	7.00	747	996	-52	219	608	578	-252	69	-386
Depreciation Expense	267	284	273	284	311	320	317	291	309	292	340
Amortization Expense	8.00	16	13	11	9.00	9.00	9.00	9.00	9.00	12	11
Non-Cash Adjustments To Reconcile Net Income	215	-148	-82	6.00	411	45	-82	-19	14	89	39
Changes in Operating Assets and Liabilities, net	-218	435	-311	-157	-29	214	-38	-104	476	-1,095	260
Net Cash From Investing Activities	-497	357	-370	-487	-483	-234	220	-284	-229	-353	-206
Net Cash From Continuing Investing Activities	-497	357	-370	-487	-483	-234	220	-284	-229	-353	-206
Purchase of Property, Plant & Equipment	-519	-338	-411	-498	-481	-267	-277	-307	-370	-360	-213
Purchase of Investments	-	-12	-	-	-2.00	27	-12	3.00	-8.00	2.00	-1.00
Sale of Property, Plant & Equipment	12	708	39	46	9.00	5.00	508	33	143	3.00	7.00
Other Investing Activities, net	-	-	0.00	-	1.00	1.00	1.00	-13	6.00	2.00	1.00
Net Cash From Financing Activities	687	-396	352	-993	-419	-449	-554	-686	172	-36	-126
Net Cash From Continuing Financing Activities	687	-396	352	-993	-419	-449	-554	-686	172	-36	-126
Repayment of Debt	-89	-385	-7.00	-720	-187	-448	-883	-69	-284	-478	14
Repurchase of Common Equity	-	0.00	-106	-644	-322	0.00	-173	-495	-69	0.00	0.00
Payment of Dividends	-105	-22	-22	-148	-164	-168	-165	-155	-148	-149	-78
Issuance of Debt	3,491	0.00	0.00	520	278	312	650	0.00	648	606	748
Other Financing Activities, net	-2,610	11	487	-1.00	-24	-145	17	33	25	-15	-810
Cash Interest Paid	103	208	208	206	204	208	180	164	223	267	251
Cash Income Taxes Paid	53	50	79	75	85	78	149	131	63	82	74

This table details how cash moves in and out of Chemours' business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025	Q4 2025
Period end date	6/30/2023	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024	3/31/2025	6/30/2025	9/30/2025	12/31/2025
Net Change in Cash & Equivalents	-76	511	351	-454	-734	50	94	-249	18	106	57
Net Cash From Operating Activities	67	131	482	-290	-620	139	138	-112	93	146	137
Net Cash From Continuing Operating Activities	67	131	482	-290	-620	139	138	-112	93	146	137
Net Income / (Loss) Continuing Operations	-376	11	-17	54	69	-27	-8.00	-4.00	-380	60	-62
Consolidated Net Income / (Loss)	-376	11	-17	54	69	-27	-8.00	-4.00	-380	60	-62
Depreciation Expense	78	76	74	71	74	78	78	88	92	79	81
Amortization Expense	2.00	2.00	3.00	3.00	3.00	3.00	3.00	3.00	3.00	3.00	2.00
Non-Cash Adjustments To Reconcile Net Income	-9.00	-30	50	-16	-5.00	73	37	-6.00	4.00	12	29
Changes in Operating Assets and Liabilities, net	372	72	372	-402	-761	12	28	-193	374	-8.00	87
Net Cash From Investing Activities	-60	58	-130	-101	-70	-75	-107	-86	-42	-35	-43
Net Cash From Continuing Investing Activities	-60	58	-130	-101	-70	-75	-107	-86	-42	-35	-43
Purchase of Property, Plant & Equipment	-58	-86	-135	-102	-73	-76	-109	-84	-43	-41	-45
Purchase of Investments	6.00	-8.00	-	-2.00	1.00	1.00	2.00	-2.00	-	-1.00	2.00
Net Cash From Financing Activities	-79	324	-5.00	-54	-40	-27	85	-57	-27	-5.00	-37
Net Cash From Continuing Financing Activities	-79	324	-5.00	-54	-40	-27	85	-57	-27	-5.00	-37
Repayment of Debt	-3.00	-275	-3.00	-3.00	-2.00	13	-486	-8.00	4.00	-98	116
Payment of Dividends	-38	-37	-36	-37	-37	-38	-37	-37	-13	-13	-15
Issuance of Debt	-	-	-	-	-	-	606	-	-	-	653
Other Financing Activities, net	-2.00	6.00	35	-14	-1.00	-2.00	2.00	-12	-113	106	-791

This table presents Chemours' assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Period end date	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025
Total Assets	6,298	3,822	7,293	7,362	7,258	7,082	7,550	7,640	8,241	7,509	7,382
Total Current Assets	2,301	902	3,493	3,293	2,777	2,633	3,345	3,214	3,844	3,017	3,001
Cash & Equivalents	366	902	1,556	1,201	943	1,105	1,451	1,102	1,203	713	670
Restricted Cash	-	-	-	-	-	-	-	0.00	-	0.00	2.00
Accounts Receivable	859	-	919	861	674	511	720	626	622	770	679
Inventories, net	972	-	935	1,147	1,079	939	1,099	1,404	1,349	1,463	1,569
Prepaid Expenses	104	-	83	84	81	78	75	82	0.00	71	80
Other Current Assets	-	-	-	-	-	-	-	-	-	0.00	1.00
Plant, Property, & Equipment, net	3,177	2,784	3,008	3,291	3,559	3,474	3,154	3,171	3,207	3,188	3,078
Plant, Property & Equipment, gross	9,015	-	8,511	8,992	9,413	9,582	9,232	9,387	0.00	9,577	9,920
Accumulated Depreciation	5,838	-	5,503	5,701	5,854	6,108	6,078	6,216	-	6,389	6,842
Total Noncurrent Assets	820	136	792	778	922	975	1,051	1,255	1,085	1,304	1,282
Long-Term Investments	136	136	173	160	162	167	169	175	158	152	160
Goodwill	176	-	166	181	153	153	102	102	0.00	46	46
Intangible Assets	-	-	-	-	21	14	6.00	13	0.00	3.00	2.00
Other Noncurrent Operating Assets	508	-	453	437	586	641	674	763	927	1,053	1,022
Other Noncurrent Nonoperating Assets	-	-	-	-	-	-	100	202	0.00	50	52
Total Liabilities & Shareholders' Equity	6,298	0.00	7,293	7,362	7,258	7,082	7,550	7,640	8,241	7,509	7,382
Total Liabilities	6,168	0.00	6,428	6,342	6,563	6,267	6,468	6,533	7,518	6,937	7,131
Total Current Liabilities	1,466	0.00	1,648	1,709	1,541	1,442	1,858	1,891	2,487	1,820	1,686
Short-Term Debt	39	-	15	13	134	21	25	43	0.00	54	42
Accounts Payable	973	-	1,075	1,137	923	844	1,162	1,233	0.00	1,156	954
Accrued Expenses	454	-	558	559	484	375	498	494	1,059	511	594
Current Employee Benefit Liabilities	-	-	-	-	-	107	173	121	0.00	99	96
Total Noncurrent Liabilities	4,702	0.00	4,780	4,633	5,022	4,825	4,610	4,642	4,526	5,117	5,445
Long-Term Debt	3,915	-	4,097	3,959	4,026	4,005	3,724	3,590	3,989	4,059	4,099
Asset Retirement Reserve & Litigation Obligation	-	-	-	-	-	295	389	474	-	456	530
Noncurrent Deferred & Payable Income Tax Liabilities	234	-	208	217	118	36	49	61	0.00	35	37
Other Noncurrent Operating Liabilities	553	-	475	457	878	489	448	517	537	567	779
Commitments & Contingencies	0.00	-	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	130	0.00	865	1,020	695	815	1,082	1,107	723	572	251
Total Preferred & Common Equity	126	0.00	860	1,014	689	813	1,081	1,107	721	571	250
Total Common Equity	126	0.00	860	1,014	689	813	1,081	1,107	0.00	571	250
Common Stock	777	-	839	862	861	892	946	1,018	0.00	1,057	1,076
Retained Earnings	-115	-	579	1,466	1,249	1,303	1,746	2,170	0.00	1,685	1,220
Treasury Stock	-	-	-116	-750	-1,072	-1,072	-1,247	-1,738	0.00	-1,804	-1,802
Accumulated Other Comprehensive Income / (Loss)	-536	-	-442	-564	-349	-310	-364	-343	0.00	-367	-244
Noncontrolling Interest	4.00	-	5.00	6.00	6.00	2.00	1.00	0.00	0.00	1.00	1.00

This table presents Chemours' assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q1 2023	Q2 2023	Q3 2023	Q1 2024	Q2 2024	Q3 2024	Q1 2025	Q2 2025	Q3 2025
Period end date	9/30/2022	3/31/2023	6/30/2023	9/30/2023	3/31/2024	6/30/2024	9/30/2024	3/31/2025	6/30/2025	9/30/2025
Total Assets	7,745	7,624	7,660	7,948	7,983	7,249	7,463	7,394	7,488	7,570
Total Current Assets	3,543	3,202	3,374	3,683	3,610	2,937	3,080	2,933	3,100	3,207
Cash & Equivalents	1,167	816	738	852	0.00	604	596	464	502	613
Accounts Receivable	980	837	890	846	813	896	951	858	959	947
Inventories, net	1,321	1,486	1,446	1,314	1,383	1,368	1,438	1,550	1,558	1,547
Prepaid Expenses	75	63	64	76	0.00	54	75	61	58	78
Other Current Assets	-	-	-	-	-	-	-	-	23	22
Plant, Property, & Equipment, net	3,071	3,180	3,190	3,119	3,200	3,157	3,173	3,131	3,121	3,090
Plant, Property & Equipment, gross	9,186	9,499	9,548	9,243	0.00	9,440	9,545	9,624	9,781	9,833
Accumulated Depreciation	6,115	6,319	6,358	6,124	-	6,283	6,372	6,493	6,660	6,743
Total Noncurrent Assets	1,131	1,242	1,096	1,146	651	1,155	1,210	1,330	1,267	1,273
Long-Term Investments	186	185	189	192	0.00	169	190	164	177	180
Goodwill	102	102	102	102	0.00	102	46	46	46	46
Intangible Assets	15	10	8.00	5.00	0.00	3.00	3.00	2.00	2.00	2.00
Other Noncurrent Operating Assets	627	740	797	847	651	881	921	1,068	991	993
Other Noncurrent Nonoperating Assets	201	205	0.00	0.00	0.00	-	50	50	51	52
Total Liabilities & Shareholders' Equity	7,745	7,624	7,660	7,948	7,983	7,249	7,463	7,394	7,488	7,570
Total Liabilities	6,460	6,396	6,850	7,191	7,228	6,524	6,804	6,814	7,249	7,270
Total Current Liabilities	1,951	1,745	2,190	2,195	2,232	1,557	1,777	1,673	1,850	1,880
Short-Term Debt	24	25	25	23	0.00	37	53	43	38	52
Accounts Payable	1,270	1,166	1,009	901	964	938	1,069	1,006	1,023	1,035
Accrued Expenses	527	471	1,078	1,177	0.00	509	566	501	710	696
Current Employee Benefit Liabilities	130	83	78	94	0.00	73	89	123	79	97
Total Noncurrent Liabilities	4,509	4,651	4,660	4,996	4,302	4,967	5,027	5,141	5,399	5,390
Long-Term Debt	3,510	3,599	3,604	3,944	3,970	3,951	3,988	4,064	4,102	4,098
Asset Retirement Reserve & Litigation Obligation	482	477	473	467	-	453	448	467	503	502
Noncurrent Deferred & Payable Income Tax Liabilities	53	60	58	54	0.00	41	41	28	23	18
Other Noncurrent Operating Liabilities	464	515	525	531	332	522	550	582	771	772
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	1,285	1,228	810	757	755	725	659	580	239	300
Total Preferred & Common Equity	1,284	1,227	808	755	753	723	657	579	237	298
Total Common Equity	1,284	1,227	808	755	1,798	723	657	579	237	298
Common Stock	1,017	1,006	1,016	1,032	0.00	1,047	1,052	1,062	1,068	1,073
Retained Earnings	2,304	2,278	1,864	1,845	1,798	1,828	1,763	1,659	1,265	1,312
Treasury Stock	-1,604	-1,751	-1,790	-1,807	0.00	-1,805	-1,805	-1,804	-1,803	-1,803
Accumulated Other Comprehensive Income / (Loss)	-433	-306	-282	-315	0.00	-347	-353	-338	-293	-284
Noncontrolling Interest	1.00	1.00	2.00	2.00	0.00	2.00	2.00	1.00	2.00	2.00

This table displays calculated financial ratios and metrics derived from Chemours' official financial filings.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Period end date	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	-11.12%	-5.54%	14.50%	7.36%	-16.75%	-10.08%	27.69%	7.66%	-11.02%	-4.87%	0.45%
EBITDA Growth	-74.97%	140.10%	191.75%	18.84%	-77.13%	91.20%	62.48%	-1.97%	-85.81%	308.64%	-50.40%
EBIT Growth	-114.72%	321.79%	532.37%	22.94%	-95.91%	605.45%	116.24%	0.36%	-118.29%	326.62%	-111.62%
NOPAT Growth	-124.80%	28.79%	1,321.15%	26.96%	-76.12%	84.32%	35.41%	-0.96%	-128.48%	234.64%	-121.57%
Net Income Growth	-122.44%	107.78%	10,571.43%	33.33%	-105.22%	521.15%	177.63%	-4.93%	-141.00%	136.29%	-659.42%
EPS Growth	-122.62%	108.00%	9,675.00%	39.39%	-105.87%	512.50%	172.73%	1.39%	-143.84%	135.63%	-658.70%
Operating Cash Flow Growth	-63.96%	226.37%	7.74%	78.13%	-42.98%	24.15%	0.87%	-7.25%	-26.36%	-213.85%	141.71%
Free Cash Flow Firm Growth	96.05%	683.89%	-53.63%	87.66%	-80.44%	405.63%	69.20%	-57.58%	-38.63%	-372.10%	-74.84%
Invested Capital Growth	0.93%	-22.28%	16.67%	11.79%	3.28%	-4.83%	-12.83%	4.82%	-13.77%	35.06%	-7.51%
Revenue Q/Q Growth	0.00%	-0.70%	4.25%	-1.63%	-1.99%	-0.28%	3.86%	-2.83%	1.23%	0.56%	-0.48%
EBITDA Q/Q Growth	0.00%	-24.56%	64.29%	-5.26%	-62.24%	227.40%	25.95%	-24.77%	19.12%	14.93%	-21.55%
EBIT Q/Q Growth	0.00%	-47.73%	97.83%	-6.40%	-91.92%	455.96%	41.01%	-30.76%	13.97%	30.71%	-184.44%
NOPAT Q/Q Growth	0.00%	-163.14%	126.55%	-9.38%	-44.51%	136.70%	14.51%	-25.26%	2.00%	-45.89%	-366.67%
Net Income Q/Q Growth	0.00%	-95.36%	158.48%	-7.95%	-112.75%	285.59%	53.92%	-36.27%	25.00%	11.69%	-20.63%
EPS Q/Q Growth	0.00%	-95.06%	167.81%	-6.36%	-113.28%	294.12%	54.51%	-34.59%	21.57%	14.00%	-20.66%
Operating Cash Flow Q/Q Growth	-51.08%	-5.11%	5.44%	-3.72%	27.70%	-5.50%	-15.12%	-5.86%	136.60%	-119.03%	-0.38%
Free Cash Flow Firm Q/Q Growth	0.00%	0.00%	118.08%	0.54%	1,281.75%	1.66%	-2.56%	-32.38%	5,450.00%	-127.24%	-6.88%
Invested Capital Q/Q Growth	0.00%	-7.20%	1.53%	-1.63%	-9.00%	-3.31%	-0.54%	-0.12%	-8.85%	-1.20%	-3.27%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Gross Margin	16.70%	20.43%	28.22%	29.69%	19.24%	21.47%	21.77%	23.66%	21.49%	19.91%	15.53%
EBITDA Margin	3.45%	8.76%	22.32%	24.71%	6.79%	14.43%	18.36%	16.72%	2.67%	11.45%	5.39%
Operating Margin	-2.31%	-1.74%	15.87%	17.82%	6.30%	7.39%	10.65%	11.30%	-4.03%	5.90%	-1.10%
EBIT Margin	-1.36%	3.20%	17.69%	20.26%	1.00%	7.81%	13.22%	12.33%	-2.53%	6.04%	-0.65%
Profit (Net Income) Margin	-1.57%	0.13%	12.08%	15.00%	-0.94%	4.41%	9.58%	8.46%	-3.90%	1.49%	-6.65%
Tax Burden Percent	47.87%	-63.64%	81.91%	86.23%	41.94%	122.35%	89.94%	78.00%	74.53%	67.72%	139.35%
Interest Burden Percent	241.03%	-6.36%	83.36%	85.87%	-225.45%	46.13%	80.57%	88.00%	206.49%	36.39%	728.95%
Effective Tax Rate	0.00%	0.00%	18.09%	13.77%	0.00%	-22.35%	10.06%	22.00%	0.00%	32.28%	0.00%
Return on Invested Capital (ROIC)	-2.59%	-2.07%	26.64%	29.66%	6.60%	12.27%	18.20%	18.90%	-5.65%	6.99%	-1.23%
ROIC Less NNEP Spread (ROIC-NNEP)	-2.45%	0.27%	24.45%	28.69%	-3.83%	4.35%	18.20%	17.74%	-8.75%	1.48%	-11.84%
Return on Net Nonoperating Assets (RNNOA)	-2.14%	12.84%	146.08%	76.02%	-12.66%	16.74%	45.90%	33.91%	-20.03%	5.81%	-92.57%
Return on Equity (ROE)	-4.73%	10.77%	172.72%	105.68%	-6.06%	29.01%	64.10%	52.81%	-25.68%	12.80%	-93.80%
Cash Return on Invested Capital (CROIC)	-3.52%	23.00%	11.26%	18.52%	3.38%	17.22%	31.92%	14.19%	9.14%	-22.85%	6.56%
Operating Return on Assets (OROA)	-1.27%	3.42%	19.69%	18.36%	0.75%	5.41%	11.47%	11.09%	-1.94%	4.43%	-0.51%
Return on Assets (ROA)	-1.47%	0.14%	13.44%	13.59%	-0.71%	3.05%	8.31%	7.61%	-2.98%	1.09%	-5.18%
Return on Common Equity (ROCE)	-4.72%	10.44%	171.72%	105.06%	-6.02%	28.85%	64.00%	52.79%	-25.65%	12.77%	-93.58%
Return on Equity Simple (ROE_SIMPLE)	-71.43%	0.00%	86.86%	98.22%	-7.55%	26.94%	56.24%	52.21%	-32.16%	14.24%	0.00%
Net Operating Profit after Tax (NOPAT)	-92	-66	804	1,020	244	449	608	602	-172	231	-45
NOPAT Margin	-1.62%	-1.22%	13.00%	15.37%	4.41%	9.04%	9.58%	8.82%	-2.82%	3.99%	-0.77%
Net Nonoperating Expense Percent (NNEP)	-0.14%	-2.33%	2.19%	0.97%	10.43%	7.92%	0.00%	1.16%	3.10%	5.50%	10.61%
Return On Investment Capital (ROIC_SIMPLE)	-	-	-	-	-	-	-	12.70%	-3.59%	4.90%	-1.02%
Cost of Revenue to Revenue	83.30%	79.57%	71.78%	70.31%	80.76%	78.53%	78.23%	76.34%	78.51%	80.09%	84.47%
SG&A Expenses to Revenue	11.05%	17.52%	10.12%	9.90%	9.92%	10.61%	9.33%	10.39%	21.22%	10.12%	13.76%
R&D to Revenue	1.70%	1.50%	1.31%	1.24%	1.45%	1.87%	1.69%	1.73%	1.78%	1.89%	1.86%
Operating Expenses to Revenue	19.01%	22.17%	12.36%	11.87%	12.94%	14.09%	11.11%	12.36%	25.52%	14.01%	16.63%
Earnings before Interest and Taxes (EBIT)	-78	173	1,094	1,345	55	388	839	842	-154	349	-38
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	197	473	1,380	1,640	375	717	1,165	1,142	162	662	313
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	5.85	0.00	8.31	3.75	3.56	4.42	4.60	3.86	6.08	4.18	7.07
Price to Tangible Book Value (P/TBV)	0.00	0.00	10.30	4.56	4.76	5.56	5.11	4.31	7.09	4.55	8.75
Price to Revenue (P/Rev)	0.13	0.57	1.16	0.57	0.44	0.72	0.78	0.63	0.74	0.44	0.30
Price to Earnings (P/E)	0.00	441.40	9.58	3.82	0.00	16.40	8.18	7.40	0.00	29.36	0.00
Dividend Yield	14.24%	0.71%	0.31%	3.78%	6.67%	4.58%	3.28%	3.53%	3.31%	5.92%	4.35%
Earnings Yield	0.00%	0.23%	10.43%	26.17%	0.00%	6.10%	12.22%	13.52%	0.00%	3.41%	0.00%
Enterprise Value to Invested Capital (EV/IC)	1.17	0.74	2.94	1.77	1.47	1.78	2.28	2.03	2.33	1.52	1.46
Enterprise Value to Revenue (EV/Rev)	0.73	0.38	1.54	0.97	1.00	1.28	1.12	0.97	1.08	1.00	0.87
Enterprise Value to EBITDA (EV/EBITDA)	21.29	4.34	6.91	3.91	14.70	8.85	6.10	5.81	40.46	8.71	16.22
Enterprise Value to EBIT (EV/EBIT)	0.00	11.86	8.72	4.77	100.23	16.36	8.47	7.88	0.00	16.53	0.00
Enterprise Value to NOPAT (EV/NOPAT)	0.00	0.00	11.87	6.29	22.63	14.14	11.69	11.01	0.00	24.98	0.00
Enterprise Value to Operating Cash Flow (EV/OCF)	23.04	3.45	14.90	5.63	8.48	7.87	8.73	8.78	11.79	0.00	19.23
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	2.80	28.09	10.07	44.24	10.07	6.67	14.67	23.62	0.00	21.32
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	30.42	0.00	4.75	3.89	5.99	4.94	3.46	3.28	5.46	6.79	16.50
Long-Term Debt to Equity	30.12	0.00	4.74	3.88	5.79	4.91	3.44	3.24	5.40	6.70	16.33
Financial Leverage	0.88	47.97	5.97	2.65	3.30	3.85	2.52	1.91	2.29	3.92	7.82
Leverage Ratio	3.22	77.85	12.85	7.77	8.52	9.50	7.71	6.94	8.61	11.73	18.09
Compound Leverage Factor	7.77	-4.95	10.71	6.68	-19.22	4.38	6.21	6.11	17.78	4.27	131.89
Debt to Total Capital	96.82%	0.00%	82.62%	79.57%	85.68%	83.16%	77.60%	76.65%	84.53%	87.16%	94.29%
Short-Term Debt to Total Capital	0.95%	0.00%	0.30%	0.26%	2.76%	0.43%	0.52%	0.91%	1.07%	1.15%	0.96%
Long-Term Debt to Total Capital	95.86%	0.00%	82.32%	79.31%	82.92%	82.73%	77.09%	75.74%	83.46%	86.02%	93.33%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.10%	0.00%	0.10%	0.12%	0.12%	0.04%	0.02%	0.00%	0.04%	0.02%	0.02%
Common Equity to Total Capital	3.09%	0.00%	17.28%	20.31%	14.19%	16.79%	22.38%	23.35%	15.43%	12.82%	5.69%
Debt to EBITDA	20.07	0.00	2.98	2.42	11.09	5.62	3.22	3.18	24.93	6.21	13.23
Net Debt to EBITDA	17.52	0.00	1.73	1.59	8.15	3.84	1.83	2.06	12.80	4.90	10.57
Long-Term Debt to EBITDA	19.87	0.00	2.97	2.41	10.74	5.59	3.20	3.14	24.61	6.12	13.10
Debt to NOPAT	-42.79	0.00	5.12	3.89	17.08	8.97	6.17	6.03	-23.55	17.79	-92.43
Net Debt to NOPAT	-37.36	0.00	2.97	2.56	12.54	6.13	3.50	3.91	-12.09	14.04	-73.86
Long-Term Debt to NOPAT	-42.37	0.00	5.10	3.88	16.53	8.92	6.13	5.96	-23.25	17.56	-91.50
Altman Z-Score	1.07	0.00	2.42	2.40	1.46	1.69	2.23	2.26	1.53	1.66	1.36
Noncontrolling Interest Sharing Ratio	0.21%	3.08%	0.58%	0.58%	0.70%	0.53%	0.16%	0.05%	0.11%	0.22%	0.24%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	1.57	0.00	2.12	1.93	1.80	1.83	1.80	1.70	1.54	1.68	1.78
Quick Ratio	0.84	0.00	1.50	1.21	1.05	1.12	1.17	0.91	0.73	0.82	0.80
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	-125	732	340	637	125	630	1,066	452	278	-755	238
Operating Cash Flow to CapEx	35.90%	0.00%	172.04%	252.21%	137.71%	308.02%	0.00%	275.55%	244.93%	-177.31%	128.16%
Free Cash Flow to Firm to Interest Expense	-0.95	3.44	1.58	2.73	0.60	2.72	5.17	2.90	1.33	-2.85	0.87
Operating Cash Flow to Interest Expense	1.38	2.79	2.98	4.89	3.13	3.48	3.95	4.84	2.66	-2.39	0.96
Operating Cash Flow Less CapEx to Interest Expense	-2.46	4.53	1.25	2.95	0.86	2.35	5.07	3.08	1.57	-3.74	0.21
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.93	1.07	1.11	0.91	0.76	0.69	0.87	0.90	0.77	0.73	0.78
Accounts Receivable Turnover	6.71	0.00	0.00	7.46	7.20	8.39	10.31	10.15	9.84	8.38	8.02
Inventory Turnover	4.71	0.00	0.00	4.48	4.01	3.87	4.87	4.17	3.46	3.28	3.24
Fixed Asset Turnover	1.76	1.81	2.14	2.11	1.61	1.41	1.91	2.16	1.90	1.81	1.85
Accounts Payable Turnover	4.72	0.00	0.00	4.22	4.33	4.42	4.95	4.35	3.99	4.03	4.65
Days Sales Outstanding (DSO)	54.43	0.00	0.00	48.94	50.69	43.52	35.41	35.96	37.11	43.56	45.53
Days Inventory Outstanding (DIO)	77.57	0.00	0.00	81.42	91.03	94.38	74.93	87.59	105.40	111.29	112.79
Days Payable Outstanding (DPO)	77.38	0.00	0.00	86.50	84.24	82.64	73.75	83.81	91.48	90.68	78.49
Cash Conversion Cycle (CCC)	54.62	0.00	0.00	43.85	57.48	55.26	36.58	39.74	51.03	64.17	79.83
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	3,582	2,784	3,248	3,631	3,750	3,569	3,111	3,261	2,812	3,798	3,487
Invested Capital Turnover	1.60	1.70	2.05	1.93	1.50	1.36	1.90	2.14	2.00	1.75	1.60
Increase / (Decrease) in Invested Capital	33	-798	464	383	119	-181	-458	150	-449	986	-283
Enterprise Value (EV)	4,193	2,052	9,538	6,419	5,512	6,347	7,105	6,632	6,555	5,769	5,077
Market Capitalization	737	3,090	7,150	3,802	2,451	3,591	4,975	4,276	4,480	2,525	1,767
Book Value per Share	$0.70	$0.00	$4.64	$5.93	$4.21	$4.94	$6.63	$7.34	$4.97	$4.04	$1.67
Tangible Book Value per Share	($0.28)	$0.00	$3.75	$4.87	$3.15	$3.93	$5.97	$6.57	$4.26	$3.71	$1.35
Total Capital	4,084	0.00	4,977	4,992	4,855	4,841	4,831	4,740	4,777	4,713	4,392
Total Debt	3,954	0.00	4,112	3,972	4,160	4,026	3,749	3,633	4,038	4,108	4,141
Total Long-Term Debt	3,915	0.00	4,097	3,959	4,026	4,005	3,724	3,590	3,987	4,054	4,099
Net Debt	3,452	-1,038	2,383	2,611	3,055	2,754	2,129	2,356	2,073	3,243	3,309
Capital Expenditures (CapEx)	507	-370	372	452	472	262	-231	274	227	357	206
Debt-free, Cash-free Net Working Capital (DFCFNWC)	508	0.00	304	396	427	107	61	264	-407	564	685
Debt-free Net Working Capital (DFNWC)	874	902	1,860	1,597	1,370	1,212	1,512	1,366	1,400	1,277	1,357
Net Working Capital (NWC)	835	902	1,845	1,584	1,236	1,191	1,487	1,323	1,349	1,223	1,315
Net Nonoperating Expense (NNE)	-2.40	-73	57	24	296	230	0.00	24	66	145	341
Net Nonoperating Obligations (NNO)	3,452	2,784	2,383	2,611	3,055	2,754	2,029	2,154	2,073	3,193	3,236
Total Depreciation and Amortization (D&A)	275	300	286	295	320	329	326	300	316	313	351
Debt-free, Cash-free Net Working Capital to Revenue	8.89%	0.00%	4.92%	5.97%	7.73%	2.15%	0.96%	3.86%	-6.70%	9.75%	11.79%
Debt-free Net Working Capital to Revenue	15.29%	16.70%	30.08%	24.06%	24.79%	24.39%	23.83%	20.00%	23.03%	22.09%	23.36%
Net Working Capital to Revenue	14.61%	16.70%	29.84%	23.86%	22.37%	23.97%	23.44%	19.37%	22.19%	21.15%	22.64%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	($0.50)	$0.04	$4.04	$5.62	($0.32)	$1.33	$3.69	$3.72	($1.60)	$0.58	($2.57)
Adjusted Weighted Average Basic Shares Outstanding	181.38M	183.15M	182.52M	167.04M	164.01M	165.17M	160.02M	148.34M	148.80M	149.44M	150.09M
Adjusted Diluted Earnings per Share	($0.50)	$0.04	$3.91	$5.45	($0.32)	$1.32	$3.60	$3.65	($1.60)	$0.57	($2.57)
Adjusted Weighted Average Diluted Shares Outstanding	181.38M	183.15M	182.52M	167.04M	164.01M	165.17M	160.02M	148.34M	148.80M	149.44M	150.09M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.04	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	181.38M	183.15M	182.52M	167.04M	164.01M	165.17M	160.02M	148.34M	148.80M	149.44M	150.09M
Normalized Net Operating Profit after Tax (NOPAT)	158	53	850	1,062	305	313	613	615	-64	309	-3.50
Normalized NOPAT Margin	2.77%	0.99%	13.75%	16.00%	5.51%	6.30%	9.67%	9.00%	-1.06%	5.35%	-0.06%
Pre Tax Income Margin	-3.29%	-0.20%	14.75%	17.40%	-2.24%	3.60%	10.65%	10.85%	-5.23%	2.20%	-4.77%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	-0.59	0.81	5.09	5.77	0.26	1.67	4.07	5.40	-0.74	1.32	-0.14
NOPAT to Interest Expense	-0.70	-0.31	3.74	4.38	1.17	1.94	2.95	3.86	-0.82	0.87	-0.16
EBIT Less CapEx to Interest Expense	-4.43	2.55	3.36	3.83	-2.00	0.54	5.19	3.64	-1.82	-0.03	-0.89
NOPAT Less CapEx to Interest Expense	-4.54	1.43	2.01	2.44	-1.10	0.81	4.07	2.10	-1.91	-0.48	-0.92
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	-116.67%	314.29%	2.95%	14.86%	-315.38%	76.71%	27.14%	26.82%	-62.45%	173.26%	-20.21%
Augmented Payout Ratio	-116.67%	314.29%	17.14%	79.52%	-934.62%	76.71%	55.59%	112.46%	-91.56%	173.26%	-20.21%

This table displays calculated financial ratios and metrics derived from Chemours' official financial filings.

Metric	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025	Q4 2025
Period end date	6/30/2023	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024	3/31/2025	6/30/2025	9/30/2025	12/31/2025
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	-14.20%	-16.32%	2.69%	-12.11%	-6.39%	0.94%	-1.35%	0.44%	3.93%	-0.86%	-2.06%
EBITDA Growth	-196.66%	-65.73%	72.22%	-32.75%	167.30%	-18.66%	138.71%	-23.20%	-153.73%	90.10%	-40.74%
EBIT Growth	-256.08%	-82.33%	62.50%	-42.36%	134.42%	-50.00%	546.67%	-51.67%	-263.71%	340.00%	-105.17%
NOPAT Growth	-246.81%	-120.27%	50.00%	-48.66%	142.50%	134.62%	-2,150.00%	-58.18%	-232.02%	731.49%	-110.00%
Net Income Growth	-287.06%	-95.00%	81.44%	-64.14%	118.62%	-325.00%	50.00%	-107.41%	-733.33%	287.50%	-376.92%
EPS Growth	-300.00%	-94.74%	78.57%	-64.58%	118.25%	-325.00%	58.33%	-108.33%	-751.28%	281.82%	-471.43%
Operating Cash Flow Growth	-76.98%	-56.48%	199.38%	-133.87%	-1,025.37%	6.11%	-71.37%	61.38%	115.00%	5.04%	-0.72%
Free Cash Flow Firm Growth	-146.88%	89.71%	383.76%	5,712.44%	-189.95%	-641.16%	-339.00%	176.66%	124.52%	146.88%	-64.30%
Invested Capital Growth	-2.79%	-5.51%	-13.77%	-11.00%	19.81%	24.60%	35.06%	-15.62%	-7.03%	-6.22%	-7.51%
Revenue Q/Q Growth	6.97%	-9.49%	-5.04%	-0.81%	13.93%	-2.41%	-7.20%	-1.79%	18.06%	-7.43%	-11.04%
EBITDA Q/Q Growth	-211.97%	142.14%	-53.73%	267.31%	12.04%	-49.07%	35.78%	0.68%	-172.48%	277.78%	-58.33%
EBIT Q/Q Growth	-296.06%	114.07%	-126.79%	568.00%	17.09%	-79.56%	139.29%	-13.43%	-450.00%	154.19%	-102.73%
NOPAT Q/Q Growth	-263.73%	84.68%	91.76%	927.86%	35.52%	-87.52%	-635.71%	147.11%	-486.79%	177.07%	-103.80%
Net Income Q/Q Growth	-359.31%	103.19%	-250.00%	300.00%	34.62%	-138.57%	66.67%	55.56%	-9,400.00%	115.79%	-203.33%
EPS Q/Q Growth	-362.50%	103.17%	-250.00%	300.00%	35.29%	-139.13%	72.22%	40.00%	-8,366.67%	115.75%	-200.00%
Operating Cash Flow Q/Q Growth	154.03%	95.52%	267.94%	-159.92%	-113.79%	122.42%	-0.72%	-181.16%	183.04%	56.99%	-6.16%
Free Cash Flow Firm Q/Q Growth	-2,007.29%	175.08%	223.91%	11.27%	-208.87%	-40.12%	-43.05%	173.17%	-82.99%	163.84%	-20.25%
Invested Capital Q/Q Growth	-10.15%	-5.83%	-8.85%	15.40%	20.96%	-2.06%	-1.20%	5.56%	-8.98%	-1.21%	-3.27%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Gross Margin	24.95%	18.36%	18.06%	21.19%	19.90%	19.05%	19.60%	17.25%	17.21%	15.59%	11.65%
EBITDA Margin	-19.35%	9.01%	4.39%	14.15%	13.91%	7.26%	10.62%	10.89%	-6.69%	12.84%	6.02%
Operating Margin	-24.10%	-3.09%	-0.35%	8.30%	8.97%	1.40%	5.03%	3.87%	-12.69%	6.29%	-0.45%
EBIT Margin	-24.22%	3.77%	-1.06%	8.67%	8.91%	1.87%	4.81%	4.24%	-12.57%	7.36%	-0.23%
Profit (Net Income) Margin	-22.89%	0.81%	-1.27%	3.85%	4.55%	-1.80%	-0.65%	-0.29%	-23.53%	4.01%	-4.66%
Tax Burden Percent	86.84%	92.31%	25.35%	77.61%	85.37%	90.00%	-112.50%	0.00%	145.59%	117.65%	92.54%
Interest Burden Percent	108.79%	23.21%	473.33%	57.27%	59.85%	-107.14%	11.94%	0.00%	128.57%	46.36%	2,233.33%
Effective Tax Rate	0.00%	7.69%	0.00%	22.39%	14.63%	0.00%	212.50%	0.00%	0.00%	-17.65%	0.00%
Return on Invested Capital (ROIC)	-31.96%	-5.40%	-0.50%	10.92%	12.20%	1.63%	-9.89%	3.58%	-13.72%	11.59%	-0.51%
ROIC Less NNEP Spread (ROIC-NNEP)	-36.23%	-2.87%	-1.18%	9.49%	10.52%	0.11%	-7.24%	2.48%	-20.88%	10.03%	-2.30%
Return on Net Nonoperating Assets (RNNOA)	-82.68%	-6.06%	-2.71%	23.51%	38.81%	0.44%	-28.37%	13.78%	-143.17%	67.89%	-18.00%
Return on Equity (ROE)	-114.64%	-11.46%	-3.20%	34.43%	51.02%	2.06%	-38.26%	17.36%	-156.89%	79.48%	-18.50%
Cash Return on Invested Capital (CROIC)	4.03%	0.16%	9.14%	4.83%	-10.98%	-9.59%	-22.85%	20.07%	6.35%	6.87%	6.56%
Operating Return on Assets (OROA)	-19.81%	2.88%	-0.81%	6.49%	6.85%	1.39%	3.53%	3.19%	-9.98%	5.71%	-0.18%
Return on Assets (ROA)	-18.72%	0.62%	-0.98%	2.88%	3.50%	-1.34%	-0.47%	-0.22%	-18.68%	3.12%	-3.64%
Return on Common Equity (ROCE)	-114.47%	-11.44%	-3.20%	34.37%	50.88%	2.06%	-38.18%	30.91%	-156.24%	79.15%	-18.46%
Return on Equity Simple (ROE_SIMPLE)	-10.89%	-41.85%	0.00%	-43.88%	16.04%	11.72%	0.00%	4.84%	0.00%	0.00%	0.00%
Net Operating Profit after Tax (NOPAT)	-277	-42	-3.50	87	118	15	-79	37	-144	111	-4.20
NOPAT Margin	-16.87%	-2.86%	-0.25%	6.44%	7.66%	0.98%	-5.65%	2.71%	-8.89%	7.40%	-0.32%
Net Nonoperating Expense Percent (NNEP)	4.28%	-2.53%	0.69%	1.42%	1.69%	1.51%	-2.65%	1.11%	7.16%	1.56%	1.80%
Return On Investment Capital (ROIC_SIMPLE)	-	-	-0.07%	-	-	-	-1.67%	0.79%	-3.28%	2.49%	-0.10%
Cost of Revenue to Revenue	75.05%	81.64%	81.94%	78.81%	80.10%	80.95%	80.40%	82.75%	82.79%	84.41%	88.35%
SG&A Expenses to Revenue	47.41%	11.10%	15.72%	10.52%	9.04%	8.99%	12.13%	8.99%	27.06%	7.29%	9.77%
R&D to Revenue	1.70%	1.88%	1.84%	2.07%	1.69%	1.93%	1.87%	1.97%	1.73%	1.74%	2.03%
Operating Expenses to Revenue	49.06%	21.45%	18.41%	12.89%	10.92%	17.65%	14.57%	13.38%	29.91%	9.30%	12.11%
Earnings before Interest and Taxes (EBIT)	-398	56	-15	117	137	28	67	58	-203	110	-3.00
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	-318	134	62	191	214	109	148	149	-108	192	80
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	6.49	5.28	6.08	5.08	4.58	4.62	4.18	3.49	7.23	7.96	7.07
Price to Tangible Book Value (P/TBV)	7.51	6.15	7.09	5.90	5.36	4.99	4.55	3.81	9.07	9.48	8.75
Price to Revenue (P/Rev)	0.83	0.66	0.74	0.65	0.58	0.53	0.44	0.35	0.29	0.41	0.30
Price to Earnings (P/E)	0.00	0.00	0.00	0.00	28.82	39.91	29.36	72.21	0.00	0.00	0.00
Dividend Yield	2.85%	3.71%	3.31%	3.89%	4.49%	4.92%	5.92%	7.39%	7.31%	4.26%	4.35%
Earnings Yield	0.00%	0.00%	0.00%	0.00%	3.47%	2.51%	3.41%	1.38%	0.00%	0.00%	0.00%
Enterprise Value to Invested Capital (EV/IC)	2.36	2.05	2.33	1.95	1.66	1.63	1.52	1.37	1.42	1.59	1.46
Enterprise Value to Revenue (EV/Rev)	1.23	1.05	1.08	1.08	1.14	1.09	1.00	0.95	0.89	0.98	0.87
Enterprise Value to EBITDA (EV/EBITDA)	19.69	46.45	40.46	91.50	10.84	10.89	8.71	8.92	16.81	14.36	16.22
Enterprise Value to EBIT (EV/EBIT)	94.39	0.00	0.00	0.00	22.09	23.48	16.53	19.17	0.00	127.34	0.00
Enterprise Value to NOPAT (EV/NOPAT)	193.98	0.00	0.00	0.00	25.69	14.69	24.98	40.14	0.00	341.08	0.00
Enterprise Value to Operating Cash Flow (EV/OCF)	19.11	26.88	11.79	16.19	0.00	0.00	0.00	0.00	20.07	21.62	19.23
Enterprise Value to Free Cash Flow (EV/FCFF)	57.80	1,263.34	23.62	37.92	0.00	0.00	0.00	6.26	21.54	22.40	21.32
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	4.48	5.24	5.46	5.32	5.50	6.13	6.79	7.08	17.32	13.83	16.50
Long-Term Debt to Equity	4.45	5.21	5.40	5.26	5.45	6.05	6.70	7.01	17.16	13.66	16.33
Financial Leverage	2.28	2.11	2.29	2.48	3.69	3.89	3.92	5.56	6.86	6.77	7.82
Leverage Ratio	7.60	7.69	8.61	7.87	9.71	10.88	11.73	11.52	15.29	15.68	18.09
Compound Leverage Factor	8.27	1.78	40.75	4.51	5.81	-11.66	1.40	0.00	19.66	7.27	404.09
Debt to Total Capital	81.75%	83.98%	84.53%	84.17%	84.62%	85.98%	87.16%	87.63%	94.54%	93.26%	94.29%
Short-Term Debt to Total Capital	0.56%	0.49%	1.07%	0.86%	0.79%	1.13%	1.15%	0.92%	0.87%	1.17%	0.96%
Long-Term Debt to Total Capital	81.19%	83.49%	83.46%	83.31%	83.83%	84.85%	86.02%	86.71%	93.67%	92.09%	93.33%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.05%	0.04%	0.04%	0.04%	0.04%	0.04%	0.02%	0.02%	0.05%	0.04%	0.02%
Common Equity to Total Capital	18.20%	15.98%	15.43%	15.79%	15.34%	13.98%	12.82%	12.35%	5.41%	6.70%	5.69%
Debt to EBITDA	9.23	29.17	24.93	58.10	6.64	7.02	6.21	6.66	13.44	10.40	13.23
Net Debt to EBITDA	6.35	17.12	12.80	36.10	5.32	5.62	4.90	5.64	11.24	8.41	10.57
Long-Term Debt to EBITDA	9.17	29.00	24.61	57.51	6.57	6.92	6.12	6.59	13.32	10.27	13.10
Debt to NOPAT	90.95	-22.67	-23.55	-17.10	15.72	9.47	17.79	29.97	-115.97	247.02	-92.43
Net Debt to NOPAT	62.53	-13.30	-12.09	-10.62	12.61	7.58	14.04	25.38	-96.95	199.82	-73.86
Long-Term Debt to NOPAT	90.33	-22.54	-23.25	-16.92	15.58	9.35	17.56	29.65	-114.90	243.93	-91.50
Altman Z-Score	1.64	1.66	1.59	1.62	1.74	1.59	1.53	1.51	1.27	1.47	1.38
Noncontrolling Interest Sharing Ratio	0.15%	0.15%	0.11%	0.15%	0.26%	0.28%	0.22%	-78.05%	0.41%	0.42%	0.24%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	1.54	1.68	1.54	1.61	1.89	1.73	1.68	1.75	1.68	1.71	1.78
Quick Ratio	0.74	0.77	0.73	0.69	0.96	0.87	0.82	0.79	0.79	0.83	0.80
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	-183	138	446	488	-531	-744	-1,065	779	133	350	279
Operating Cash Flow to CapEx	101.52%	0.00%	370.77%	-292.93%	-849.32%	182.89%	126.61%	-133.33%	221.43%	417.14%	304.44%
Free Cash Flow to Firm to Interest Expense	-3.82	2.46	7.07	7.74	-8.05	-10.79	-15.89	11.80	1.98	5.14	3.82
Operating Cash Flow to Interest Expense	1.40	2.34	7.65	-4.60	-9.39	2.01	2.06	-1.70	1.39	2.15	1.88
Operating Cash Flow Less CapEx to Interest Expense	0.02	3.41	5.59	-6.17	-10.50	0.91	0.43	-2.97	0.76	1.63	1.26
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.82	0.77	0.77	0.75	0.77	0.75	0.73	0.75	0.79	0.78	0.78
Accounts Receivable Turnover	6.44	6.58	9.84	7.17	6.42	6.40	8.38	6.93	6.31	6.15	8.02
Inventory Turnover	3.66	3.61	3.46	3.21	3.28	3.36	3.28	3.19	3.26	3.23	3.24
Fixed Asset Turnover	2.00	1.94	1.90	1.83	1.81	1.83	1.81	1.83	1.86	1.86	1.85
Accounts Payable Turnover	4.33	4.38	3.99	4.34	4.74	4.69	4.03	4.76	4.87	4.58	4.65
Days Sales Outstanding (DSO)	56.72	55.50	37.11	50.90	56.82	57.04	43.56	52.69	57.88	59.35	45.53
Days Inventory Outstanding (DIO)	99.60	101.20	105.40	113.72	111.26	108.78	111.29	114.25	111.81	113.12	112.79
Days Payable Outstanding (DPO)	84.39	83.38	91.48	84.15	76.98	77.87	90.68	76.74	74.93	79.73	78.49
Cash Conversion Cycle (CCC)	71.93	73.32	51.03	80.46	91.10	87.95	64.17	90.20	94.75	92.74	79.83
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	3,276	3,085	2,812	3,245	3,925	3,844	3,798	4,009	3,649	3,605	3,487
Invested Capital Turnover	1.89	1.89	2.00	1.70	1.59	1.66	1.75	1.32	1.54	1.57	1.60
Increase / (Decrease) in Invested Capital	-94	-180	-449	-401	649	759	986	-742	-276	-239	-283
Enterprise Value (EV)	7,740	6,317	6,555	6,313	6,517	6,270	5,769	5,502	5,177	5,730	5,077
Market Capitalization	5,243	3,987	4,480	3,820	3,315	3,033	2,525	2,022	1,714	2,371	1,767
Book Value per Share	$5.42	$5.10	$4.97	$5.05	$4.86	$4.40	$4.04	$3.87	$1.58	$1.99	$1.67
Tangible Book Value per Share	$4.68	$4.38	$4.26	$4.35	$4.15	$4.07	$3.71	$3.55	$1.26	$1.67	$1.35
Total Capital	4,439	4,724	4,777	4,763	4,713	4,700	4,713	4,687	4,379	4,450	4,392
Total Debt	3,629	3,967	4,038	4,009	3,988	4,041	4,108	4,107	4,140	4,150	4,141
Total Long-Term Debt	3,604	3,944	3,987	3,968	3,951	3,988	4,054	4,064	4,102	4,098	4,099
Net Debt	2,495	2,328	2,073	2,491	3,200	3,235	3,243	3,479	3,461	3,357	3,309
Capital Expenditures (CapEx)	66	-60	130	99	73	76	109	84	42	35	45
Debt-free, Cash-free Net Working Capital (DFCFNWC)	264	64	-407	54	798	740	564	839	786	766	685
Debt-free Net Working Capital (DFNWC)	1,209	1,511	1,400	1,407	1,417	1,356	1,277	1,303	1,288	1,379	1,357
Net Working Capital (NWC)	1,184	1,488	1,349	1,366	1,380	1,303	1,223	1,260	1,250	1,327	1,315
Net Nonoperating Expense (NNE)	99	-54	15	35	48	42	-70	41	237	51	58
Net Nonoperating Obligations (NNO)	2,466	2,328	2,073	2,491	3,200	3,185	3,193	3,429	3,410	3,305	3,236
Total Depreciation and Amortization (D&A)	80	78	77	74	77	81	81	91	95	82	83
Debt-free, Cash-free Net Working Capital to Revenue	4.19%	1.07%	-6.70%	0.92%	13.91%	12.87%	9.75%	14.50%	13.44%	13.13%	11.79%
Debt-free Net Working Capital to Revenue	19.21%	25.17%	23.03%	24.09%	24.70%	23.58%	22.09%	22.51%	22.02%	23.63%	23.36%
Net Working Capital to Revenue	18.81%	24.78%	22.19%	23.39%	24.06%	22.66%	21.15%	21.77%	21.37%	22.74%	22.64%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	($2.52)	$0.13	($0.13)	$0.35	$0.47	($0.18)	($0.06)	($0.03)	($2.54)	$0.40	($0.40)
Adjusted Weighted Average Basic Shares Outstanding	148.08M	148.44M	148.80M	148.90M	149.27M	149.41M	149.44M	149.67M	149.70M	149.89M	150.09M
Adjusted Diluted Earnings per Share	($2.52)	$0.13	($0.12)	$0.34	$0.46	($0.18)	($0.05)	($0.03)	($2.54)	$0.40	($0.40)
Adjusted Weighted Average Diluted Shares Outstanding	148.08M	148.44M	148.80M	148.90M	149.27M	149.41M	149.44M	149.67M	149.70M	149.89M	150.09M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	148.08M	148.44M	148.80M	148.90M	149.27M	149.41M	149.44M	149.67M	149.70M	149.89M	150.09M
Normalized Net Operating Profit after Tax (NOPAT)	-278	74	4.90	90	120	85	55	60	-131	69	-1.40
Normalized NOPAT Margin	-16.91%	4.97%	0.35%	6.67%	7.83%	5.69%	3.92%	4.40%	-8.11%	4.59%	-0.11%
Pre Tax Income Margin	-26.35%	0.87%	-5.03%	4.96%	5.33%	-2.00%	0.57%	0.00%	-16.16%	3.41%	-5.04%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	-8.29	1.00	-0.24	1.86	2.08	0.41	1.00	0.88	-3.03	1.62	-0.04
NOPAT to Interest Expense	-5.78	-0.76	-0.06	1.38	1.78	0.21	-1.18	0.56	-2.14	1.63	-0.06
EBIT Less CapEx to Interest Expense	-9.67	2.07	-2.30	0.29	0.97	-0.70	-0.63	-0.39	-3.66	1.10	-0.66
NOPAT Less CapEx to Interest Expense	-7.15	0.31	-2.12	-0.19	0.68	-0.89	-2.80	-0.71	-2.77	1.11	-0.67
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	-172.73%	-47.47%	-62.45%	-44.85%	126.72%	192.21%	173.26%	532.14%	-30.34%	-31.25%	-20.21%
Augmented Payout Ratio	-484.09%	-114.87%	-91.56%	-61.52%	142.24%	192.21%	173.26%	532.14%	-30.34%	-31.25%	-20.21%

Financials Breakdown Chart

Key Financial Trends

Here are the key takeaways from Chemours (NYSE: CC) focusing on the last four years of quarterly data (through Q4 2025). The bullets highlight notable trends in cash flow, profitability, leverage, and balance-sheet posture that retail investors may care about when evaluating the stock’s operating momentum and liquidity.

Operating cash flow from continuing operations turned positive in Q3 2025 and remained robust in Q4 2025 (Net cash from continuing operating activities: about $146.0M in Q3 2025 and $137.0M in Q4 2025).
A substantial debt issuance of about $653.0M occurred in Q4 2025, providing a liquidity boost via financing activities.
Net change in cash and equivalents was a positive $57.0M in Q4 2025, contributing to a stronger near-term liquidity position.
Non-cash adjustments to reconcile net income added approximately $29.0M to cash flow in Q4 2025, aiding cash generation.
Changes in operating assets and liabilities netted about $87.0M in cash during Q4 2025, supporting operating cash flow.
Long-term debt remained around $4.1B through 2025 (roughly stable from prior quarters), indicating a consistently high leverage base.
Total assets stood near $7.57B by Q3 2025, with a gradual increase over 2024–2025, reflecting portfolio growth and asset base expansion.
Net income attributable to common shareholders remained negative in Q4 2025 (-$61.0M), continuing profitability challenges.
Gross margin compressed in Q4 2025 to about 11.7% (Gross profit around $155.0M on $1,330.0M revenue) vs roughly 15.6% in Q3 2025, signaling weaker profitability per dollar of revenue.
Interest expense remained elevated at about $73.0M in Q4 2025, weighing on pretax income and overall margin.

05/07/26 04:13 AM ETAI Generated. May Contain Errors.

Frequently Asked Questions About Chemours' Financials

When does Chemours' financial year end?

According to the most recent income statement we have on file, Chemours' fiscal year ends in December. Their fiscal year 2025 ended on December 31, 2025.

How has Chemours' net income changed over the last 10 years?

Chemours' net income appears to be on a downward trend, with a most recent value of -$386 million in 2025, rising from -$90 million in 2015. The previous period was $69 million in 2024. Check out Chemours' forecast to explore projected trends and price targets.

What is Chemours' operating income?

Chemours' total operating income in 2025 was -$64 million, based on the following breakdown:

Total Gross Profit: $902 million
Total Operating Expenses: $966 million

How has Chemours' revenue changed over the last 10 years?

Over the last 10 years, Chemours' total revenue changed from $5.72 billion in 2015 to $5.81 billion in 2025, a change of 1.6%.

How much debt does Chemours have?

Chemours' total liabilities were at $7.13 billion at the end of 2025, a 2.8% increase from 2024, and a 15.6% increase since 2015.

How much cash does Chemours have?

In the past 10 years, Chemours' cash and equivalents has ranged from $366 million in 2015 to $1.56 billion in 2017, and is currently $670 million as of their latest financial filing in 2025.

How has Chemours' book value per share changed over the last 10 years?

Over the last 10 years, Chemours' book value per share changed from 0.70 in 2015 to 1.67 in 2025, a change of 139.6%.

Related Companies

Financial statements for NYSE:CC last updated on 2/27/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Chemours (CC) Financials

Financials Breakdown Chart

Key Financial Trends

Frequently Asked Questions About Chemours' Financials

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Chemours (CC) Financials

Annual Income Statements for Chemours

Quarterly Income Statements for Chemours

Annual Cash Flow Statements for Chemours

Quarterly Cash Flow Statements for Chemours

Annual Balance Sheets for Chemours

Quarterly Balance Sheets for Chemours

Annual Metrics And Ratios for Chemours

Quarterly Metrics And Ratios for Chemours

Financials Breakdown Chart

Key Financial Trends

Frequently Asked Questions About Chemours' Financials

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools